See every side of every news story
Get Started
SubscribeLogin
Published • loading... • Updated

Drug innovation should benefit patients. PBMs are preventing that from happening.

Summary by healthcaredive.com
Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, argues Kathy Chang, head of trade relations at Blue Shield of California.

1 Articles

healthcaredive.comhealthcaredive.com
Center

Drug innovation should benefit patients. PBMs are preventing that from happening.

Health plans should directly contract with drug manufacturers to provide medications at transparent and affordable prices, argues Kathy Chang, head of trade relations at Blue Shield of California.

Read Full Article
Think freely.Subscribe and get full access to Ground NewsSubscriptions start at $9.99/yearSubscribe

Bias Distribution

  • 100% of the sources are Center
100% Center

Factuality 

To view factuality data please Upgrade to Premium

Ownership

To view ownership data please Upgrade to Vantage

healthcaredive.com broke the news in on Tuesday, July 29, 2025.
Sources are mostly out of (0)
Stories disproportionately reported by the Left or the Right

Similar News Topics

Sacramento icon

Sacramento

News
For You
SearchBlindspotLocal